Latest Technology News

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.

ResMed Inc. posted a robust second quarter for fiscal year 2025, with revenue climbing 10% to $1.3 billion and operating profit soaring 52%, driven by strong demand for sleep and breathing health products and operational efficiencies.

New Frontier Minerals Limited has reshaped its portfolio by divesting the Cangai Copper Mine and acquiring the highly prospective Harts Range Project, positioning itself at the forefront of critical mineral exploration.

Weebit Nano has solidified its position in the semiconductor memory sector by signing a major licensing agreement with onsemi and raising A$50 million in capital. The company is well-funded and advancing multiple commercial and technical milestones.

Volt Group Limited reported a robust 20% increase in FY24 revenue receipts, driven by strong EcoQuip growth and strategic contract wins, while advancing its zero-emission ATEN technology with promising trials underway.

Finder Energy reports significant progress in its Kuda Tasi and Jahal oil fields development, including promising production simulations and active partner engagement for funding. The company also advances exploration efforts in the UK North Sea and Australia, maintaining a solid cash position.

Carnegie Clean Energy has secured significant funding and made key progress in its ACHIEVE Programme, setting the stage for CETO wave energy deployment in the Basque Country in 2025.

Titomic Limited has secured AUD 30 million in equity funding and appointed new leadership as it establishes a U.S. headquarters in Huntsville, Alabama, aiming to capitalize on growing aerospace and defense demand.

Paradigm Biopharmaceuticals has appointed Advanced Clinical as the Clinical Research Organisation for its critical Phase 3 trial targeting knee osteoarthritis pain, setting the stage for patient recruitment and dosing in Q2 2025.

First Graphene Limited reports a robust December quarter with new patents, expanded distribution networks, and advancing commercial trials, positioning the company on a path to cash breakeven.

Adisyn Ltd has completed its transformative acquisition of 2D Generation, securing a $10 million capital raise to accelerate development of graphene-enhanced semiconductor technologies. The company is positioning itself to disrupt key markets including defence, data centres, and cybersecurity.

TrivarX has solidified its regulatory strategy for the pivotal MEB-001 trial with the FDA and unveiled a new algorithm that expands its mental health screening reach beyond sleep clinics.